BNBX Overview

BNB Plus Corp., formerly Applied DNA Sciences, Inc., is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The Company is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.

Wall Street analysts forecast BNBX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BNBX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

BNB Plus Corp revenue for the last quarter amounts to 199.00K USD, decreased -59.10 % YoY.

BNB Plus Corp. EPS for the last quarter amounts to -3.99 USD, decreased -97.71 % YoY.

BNB Plus Corp (BNBX) has 26 emplpoyees as of January 31 2026.

Today BNBX has the market capitalization of 6.00M USD.